CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $182,000 | -14.2% | 15,000 | 0.0% | 0.09% | -19.8% |
| Q3 2019 | $212,000 | +26.9% | 15,000 | 0.0% | 0.12% | +30.3% |
| Q2 2019 | $167,000 | -5.1% | 15,000 | 0.0% | 0.09% | -5.3% |
| Q1 2019 | $176,000 | -12.0% | 15,000 | 0.0% | 0.09% | -23.0% |
| Q4 2018 | $200,000 | -4.8% | 15,000 | 0.0% | 0.12% | +8.0% |
| Q3 2018 | $210,000 | -11.0% | 15,000 | 0.0% | 0.11% | -15.7% |
| Q2 2018 | $236,000 | -4.5% | 15,000 | 0.0% | 0.13% | -15.7% |
| Q1 2018 | $247,000 | -8.9% | 15,000 | 0.0% | 0.16% | -7.0% |
| Q4 2017 | $271,000 | -6.6% | 15,000 | 0.0% | 0.17% | -8.6% |
| Q3 2017 | $290,000 | +63.8% | 15,000 | 0.0% | 0.19% | +55.8% |
| Q2 2017 | $177,000 | +142.5% | 15,000 | +50.0% | 0.12% | +110.5% |
| Q4 2016 | $73,000 | -71.9% | 10,000 | -75.0% | 0.06% | -72.1% |
| Q3 2016 | $260,000 | +19.3% | 40,000 | 0.0% | 0.20% | +16.6% |
| Q2 2016 | $218,000 | +16.6% | 40,000 | 0.0% | 0.18% | +17.4% |
| Q1 2016 | $187,000 | +21.4% | 40,000 | 0.0% | 0.15% | +10.4% |
| Q4 2015 | $154,000 | – | 40,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,372,001 | $98,287,000 | 4.68% |
| TANAKA CAPITAL MANAGEMENT INC | 79,574 | $934,000 | 2.82% |
| Consonance Capital Management LP | 3,747,453 | $43,995,000 | 2.78% |
| S&T BANK/PA | 613,740 | $7,205,000 | 1.62% |
| AJ WEALTH STRATEGIES, LLC | 595,834 | $6,995,000 | 1.16% |
| Capital Impact Advisors, LLC | 193,694 | $2,522,000 | 1.12% |
| TEALWOOD ASSET MANAGEMENT INC | 154,615 | $1,815,000 | 0.77% |
| AMI ASSET MANAGEMENT CORP | 722,932 | $8,487,000 | 0.63% |
| Birchview Capital, LP | 50,000 | $587,000 | 0.37% |
| FEDERATED HERMES, INC. | 11,176,281 | $131,210,000 | 0.32% |